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Editorials
Expectations for the United Nations high-level meeting on 
noncommunicable diseases
Devi Sridhar,a J Stephen Morrisonb & Peter Piotc
The United Nations General Assembly’s 
decision to convene a high-level meeting on 
the prevention and control of noncommu-
nicable diseases (NCDs) worldwide in Sep-
tember 2011 is a major, timely opportunity 
to elevate chronic diseases onto the global 
stage and to encourage action by individual 
governments.1 Just as the 2001 United 
Nations General Assembly Special Session 
on HIV/AIDS was a pivotal moment in 
the global response to AIDS, there is hope 
that the September session on NCDs will 
become an historic rallying point.
How shall we judge the success of the 
meeting? If Member States can address the 
following five critical elements, then new 
measurable goals and means of building 
accountability may be within reach.
First, the meeting should put a spot-
light on the true scale of morbidity and 
mortality caused by NCDs and the eco-
nomic consequences for households, health 
systems and national economies. It should 
result in an endorsement of the World 
Health Organization (WHO) Action plan 
for the global strategy for the prevention 
and control of noncommunicable diseases2 
and a commitment to a study of their pro-
jected economic impact as well as the cost 
of preventive action.
Second, governments should com-
mit to developing national NCD plans 
by convening, for example, a multisectoral 
national task force or commission to elabo-
rate country-specific strategies and targets. 
WHO could support countries in this 
process. These plans should be required by 
2013, with updates on specific targets by 
2015 and continuous monitoring by the 
United Nations.
The third key element of success is 
financing. It is unlikely that there will 
be new funds pledged at the meeting. 
In fact, it could be detrimental to focus 
on raising a specific amount of funding 
as this might distract governments from 
other key tasks. Rather than establishing a 
new institution such as a Global Fund for 
NCDs or expanding the mandate of the 
Global Fund to Fight AIDS, Tuberculo-
sis and Malaria, we suggest three feasible 
financial avenues. These are: (i) seeking 
joint financing mechanisms such as pub-
lic–private partnerships;3 (ii) investing in 
health system reform to deal better with 
NCDs, e.g. supply of essential drugs and 
devices, health worker retention, provision 
of diabetes care through primary providers; 
and (iii) including NCDs as a line item 
in government health budgets and donor 
reporting systems to help monitor budget-
ary allocations.
A fourth requirement is the commit-
ment of governments to strengthening 
national regulation of NCD risk factors, 
including pushing for change in the food 
and beverage industry. This should put into 
force regulatory frameworks to reduce con-
sumption of trans-fatty acids, salt, alcohol 
and sugar.
Finally, incentives and mechanisms to 
encourage cross-sectoral action and coor-
dination are central to sustained progress. 
Finance ministries need to budget sufficient 
funds; agriculture ministries to reduce sub-
sidies for harmful crops; trade ministries to 
enlarge access to essential medicines; urban 
planning and transport ministries to create 
opportunities for greater physical activity; 
and education ministries to ensure that 
school environments provide healthy diets 
through banning the sale and distribution 
of harmful foods in schools and promoting 
health education.
Tobacco control efforts could lead 
discussions in each of these areas given 
that there have been considerable policy 
gains. These include the WHO Framework 
Convention on Tobacco Control and the 
practical assistance provided to governments 
through WHO’s MPOWER resources; 
commitments of more than US$ 500 million 
from the Bloomberg Family Foundation and 
the Bill & Melinda Gates Foundation; and 
increasing attention to the role of tobacco in 
bilateral trade agreements, in taxation policy 
and in agriculture.
Despite such progress, there is still 
much work required to curb tobacco use 
as it is the single most important risk factor 
for NCDs and kills an estimated 5 million 
people annually. If the United Nations Sec-
retary-General makes a strong declaration 
to support the WHO Framework Con-
vention on Tobacco Control in New York 
this year, this will add significant weight 
to previous commitments to the Conven-
tion made in Geneva. While tobacco use 
is declining in most wealthy countries, it 
is increasing in many poor countries of the 
world, with profound consequences for 
the future of public health and develop-
ment. As stock prices for tobacco continue 
to rise – underscoring the confidence of 
the markets in tobacco – clear decisions 
must be made on overcoming barriers to 
implementation of the WHO Framework 
Convention on Tobacco Control. These 
include: investment treaties and associ-
ated pressures to open markets; agriculture 
and loss of employment, and subsidies for 
harmful crops; difficulties in regulating 
the private sector; illicit trade in cigarettes 
and tobacco smuggling; and constraints to 
implementing tobacco taxation.
We hold high expectations for what 
can be achieved at this high-level meeting, 
especially if Member States are willing to 
develop and support a strong outcomes 
document with agreed set targets and 
reporting mechanisms to ensure account-
ability to commitments. This is a crucial 
first step in stemming the global epidemic 
in NCDs. ■
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